Beaird Harris Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$592K Buy
493
+10
+2% +$10.2K 0.04% 88
2026
Q1
$445K Sell
483
-14
-3% -$14.2K 0.03% 101
2025
Q4
$535K Sell
497
-75
-13% -$71.7K 0.04% 88
2025
Q3
$437K Buy
572
+72
+14% +$53.6K 0.03% 100
2025
Q2
$390K Sell
500
-2
-0.4% -$1.55K 0.03% 102
2025
Q1
$415K Buy
502
+7
+1% +$5.83K 0.04% 92
2024
Q4
$382K Buy
495
+65
+15% +$53.8K 0.03% 98
2024
Q3
$381K Sell
430
-82
-16% -$73.7K 0.03% 101
2024
Q2
$464K Buy
512
+11
+2% +$8.8K 0.04% 80
2024
Q1
$390K Buy
501
+48
+11% +$34.2K 0.04% 82
2023
Q4
$264K Buy
453
+67
+17% +$39.1K 0.03% 95
2023
Q3
$207K Sell
386
-38
-9% -$19.6K 0.02% 96
2023
Q2
$199K Sell
424
-62
-13% -$26K 0.02% 98
2023
Q1
$167K Sell
486
-47
-9% -$15.9K 0.03% 94
2022
Q4
$195K Buy
533
+47
+10% +$16.7K 0.04% 89
2022
Q3
$157K Buy
486
+176
+57% +$55.8K 0.03% 89
2022
Q2
$101K Buy
310
+114
+58% +$34.2K 0.03% 94
2022
Q1
$56K Buy
196
+10
+5% +$2.57K 0.02% 179
2021
Q4
$51K Buy
+186
New +$47.2K 0.02% 233

Other funds holding LLY

Beaird Harris Wealth Management's LLY Position: Q2 2026 in Review

Beaird Harris Wealth Management increased its Eli Lilly (LLY) stake by 2.1% in Q2 2026, buying an estimated $10.2K and bringing the position to 493 shares worth $592K. The position accounts for 0.04% of the portfolio, ranked #88.

Beaird Harris Wealth Management first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Beaird Harris Wealth Management held 493 shares of Eli Lilly worth $592K as of Q2 2026.
  • Beaird Harris Wealth Management bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.04% of Beaird Harris Wealth Management's portfolio in Q2 2026, its #88 holding.
  • Beaird Harris Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Beaird Harris Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.